Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00308373 · ClinicalTrials.gov registry record · NA
Effects of Fats on Blood Glucose in People With and Without Type 2 Diabetes Mellitus
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 73
- Enrollment target
NCT00308373: Completed NA study, sponsored by Mayo Clinic.
NCT00308373 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 73 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00308373, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 73 participants
- Enrollment target
Study Summary
People with type 2 diabetes mellitus (earlier known as maturity onset diabetes mellitus) have high blood levels of sugar and fat. This study is being done to determine if excessive sugar entering the blood in people with type 2 diabetes mellitus is caused by excessive fat. We will also evaluate how the anti-diabetic medications, pioglitazone and metformin taken by mouth work to control blood sugar in people with diabetes.
Interventions
- DRUG Metformin vs Thiazolidinedione (Pioglitazone)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2004-07 |
| Est. Completion | 2005-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00308373
The ClinicalTrials.gov registry entry for NCT00308373 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Metformin vs Thiazolidinedione (Pioglitazone) is the first listed.
NCT00308373 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00308373 about?
NCT00308373 is a clinical study titled "Effects of Fats on Blood Glucose in People With and Without Type 2 Diabetes Mellitus". People with type 2 diabetes mellitus (earlier known as maturity onset diabetes mellitus) have high blood levels of sugar and fat. This study is being done to determine if excessive sugar entering the blood in people with type 2 diabetes mellitus is caused by excessive fat. We will also evaluate how ...
What is the current status of trial NCT00308373?
This trial is currently completed. It is a NA study. The enrollment target is 73 participants. The study started on 2004-07. Estimated completion is 2005-11.
What interventions are being tested in trial NCT00308373?
The interventions under investigation include: Metformin vs Thiazolidinedione (Pioglitazone) (DRUG).
Who is sponsoring clinical trial NCT00308373?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.